Luye has the right medicine with $764m IPO
Luye Pharma Group opened books for its HK$5.9bn ($764m) Hong Kong IPO on June 23 as the leads look to take advantage of the company’s strong credentials in the healthcare sector.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: